Skip to main content

Shares of NRx Pharmaceuticals drop on news of $30M stock sale

The company recently received its first regulatory approval for its Covid-19 treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.